Company Number: 15113256

Analysis Date: 2025-07-20 14:17 UTC

1. Credit Opinion: CONDITIONAL APPROVAL
   Premier GP Limited is a newly incorporated micro-entity operating in general medical practice. The company's current financial position shows net liabilities of £972 with current liabilities (£83,055) slightly exceeding current assets (£82,083), indicating very tight working capital. While the business is operational with five employed doctors as directors, the negative net assets and marginal liquidity position require close monitoring. Approval is recommended on a conditional basis, subject to periodic review of cash flow and profitability trends as the company matures beyond its initial year.

2. Financial Strength:
   The balance sheet reveals net liabilities of £972, reflecting a small deficit in shareholders' funds. Current liabilities marginally exceed current assets by about £972, implying limited short-term financial buffer. As a micro-entity, fixed assets are not disclosed, but given the nature of the medical practice, capital intensity is likely low. The negative equity position is not alarming given the company's infancy but highlights the need for improved retained earnings or capital injection to strengthen the balance sheet.

3. Cash Flow Assessment:
   Current assets of £82,083, presumably including cash and receivables, are nearly sufficient to cover current liabilities of £83,055. This tight working capital suggests limited liquidity headroom, increasing the risk of cash flow stress if payments are delayed or expenses increase unexpectedly. The company’s ability to generate positive operating cash flows is critical to meet obligations. The lack of a profit and loss account limits detailed cash flow analysis, but ongoing operational revenue from medical services is expected.

4. Monitoring Points:

• Quarterly review of cash flow and working capital position to ensure liabilities are met on time.
• Profitability trends as future accounts are filed, including any build-up of retained earnings to improve equity.
• Director engagement and any capital infusion plans to address negative net asset position.
• Payment performance with suppliers and any emerging credit risks linked to tight liquidity.